AVMA news
Genomic tests show promise for early detection of canine cancers
Emerging technology in the field of veterinary diagnostics is finding canine cancer in the early stage of the disease, meaning treatment can start…
JAVMA news
Company takes canine cancer drug off market to study dosing
Oasmia Pharmaceutical AB has taken a canine cancer drug, Paccal Vet, or paclitaxel for injection, off the market to study lowering the
AVMA news
In Short - Jan. 15, 2022
Cornell receives $30 million toward its Canine Health Center and a survey delves into veterinarians' understanding and practice of oncology around the…
JAVMA news
FDA conditionally approves drug for treating lymphoma in dogs
The Food and Drug Administration announced Jan. 3 that it has conditionally approved Tanovea-CA1, or rabacfosadine, as the first animal drug to treat…
AVMA news
Drug approved to treat dogs for chemotherapy-related diarrhea
Food and Drug Administration officials granted conditional approval in mid-December for the oral prescription drug Canalevia-CA1, the first drug with…
AVMA news
New listings in AVMA Animal Health Studies Database – April 2022
Veterinary studies recently listed in the AVMA Animal Health Studies Database include a new study from the Comparative Oncology Trials Consortium,…
AVMA news
AVMA honors four veterinary scientists
The Association hailed Drs. Yrjö Gröhn, Stephen White, Stanley Marks, and Mike Nolan for promoting animal and human health through their notable…
JAVMA news
Foundation receives $1M grant for osteosarcoma research
The Petco Foundation and the Blue Buffalo Foundation have partnered to sponsor a $1 million grant for Morris Animal Foundation to help fund research…